یادداشتهای مربوط به کتابنامه ، واژه نامه و نمایه های داخل اثر
متن يادداشت
Includes bibliographical references and index.
یادداشتهای مربوط به مندرجات
متن يادداشت
Overview of existing therapies / Jiannis Mountzios and Jean-Charles Soria -- Signal transduction inhibitors, HER family, EGFR inhibition, and clinical achievements / Giuseppe Giaccone and Paolo Zucali -- HER2 inhibition and clinical achievements / Toru Mukohara and Pasi A. Jänne -- Pan-HER inhibitors / Gérard Milano -- Inhibiting the phosphoinositide 3-kinase/Akt/mammalian target of rapamycin pathway / Janet E. Dancey -- Farnesyl transferase inhibitors in cancer: promise, but limited proof / Laura Fanucchi, Michael P. Fanucchi, and Fadlo R. Khuri -- Protein Kinase C inhibitors in the treatment of non-small cell lung cancer / Yun Oh [and others] -- Signal transduction inhibitors: PDGFR and c-KIT inhibitors / Jean-Yves Blay [and others] -- The insulin-like growth factor 1 receptor: a target for cancer treatment / Yungan Tao, Jean Bourhis, and Eric Deutsch -- Aurora kinase inhibitors / Mitesh J. Borad, Steven L. Warner, and Daniel D. von Hoff -- Apoptosis modulators: p53 targeting / Sunil Chada [and others] -- Survivin / Dario C. Altieri -- TRAIL modulators / C.H. Mom [and others] -- VEGF targeting / Lee M. Ellis -- Targeting angiogenesis with oral agents / Benjamin Besse and Jean-Pierre Armand -- Endothelial cell propagation targteing / Gordon C. Tucker -- HIF-1 inhibitors / Giovanni Melillo -- Antivascular agents / Jane Robertson -- Matrix metalloproteinases / Stéphane Vignot and Jean-Philippe Sapno -- Src inhibitors / Francisco Cruzalegui -- Telomerase and Telomere interacting agents / Jean-Franc̦oi Riou [and others] -- Targeting Hsp90: the cancer super-chaperone / Paul Workman and Swee Sharp.
بدون عنوان
0
یادداشتهای مربوط به خلاصه یا چکیده
متن يادداشت
This book presents an authoritative overview of existing molecular targeted therapies, their relevance and role for specific tumors, and their clinical efficacy and impact on patient treatment.